We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Cholesterol Enzyme Found on Lipid Droplets

By Biotechdaily staff writers
Posted on 15 Dec 2003
Researchers have used labeled proteins in conjunction with confocal microscopy to show that the NSDHL (NAD(P)H steroid dehydrogenase-like) enzyme, which is involved in cholesterol synthesis, is located on the surface of endoplasmic reticulum derived lipid droplets.

Mutations in the gene that codes for NSDHL are associated with human CHILD syndrome (congenital hemidysplasia with ichthyosiform nevus and limb defects), an X-linked, male lethal disorder. More...
Investigators at Ohio State University (Columbus, USA) used a mouse model to determine the location of the enzyme among the cell's subcellular organelles. They reported in the November 15, 2003, issue of Human Molecular Genetics that in addition to being located in the endoplasmic reticulum, the common site for enzymes of post-squalene cholesterol biosynthesis, NSDHL was also found associated with lipid droplets, which are endoplasmic reticulum (ER)-derived cytoplasmic structures that contain a neutral lipid core.

"Cholesterol is necessary for the survival of all cells in the body, and research has now identified cholesterol as also being important in the development of a fetus,” explained senior author Dr. Gail Herman, professor of pediatrics at Ohio State University. "Using models, we identified genetic changes in enzymes that cause two of the disorders. While studying how the NSDHL protein works, we found that it coats the surface of lipid droplets.”



Related Links:
Ohio State University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.